Advanced Biomed (ADVB) EPS (Basic) (2023 - 2026)

Advanced Biomed has reported EPS (Basic) for 3 years, with the latest figure at -$0.13 in Q4 2025.

• Quarterly EPS (Basic) rose 59.4% year-over-year to -$0.13 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$1.58 (down 1.66% YoY) and the FY2025 annual result came in at -$3.18, down 14.13% from the prior year.
• EPS (Basic) improved to -$0.13 in Q4 2025 per ADVB's latest filing, from -$0.36 in the prior quarter.
• Over five years, EPS (Basic) peaked at -$0.13 in Q4 2025 and troughed at -$1.46 in Q2 2025.
• A 3-year average of -$0.53 and a median of -$0.33 in 2024 frame the typical range for EPS (Basic).
• The sharpest annual moves came in 2024 and 2025: EPS (Basic) tumbled 125.95% in 2024, then jumped 82.77% in 2025.
• Over 3 years, EPS (Basic) stood at -$0.15 in 2023, then plunged by 125.95% to -$0.33 in 2024, then jumped by 59.4% to -$0.13 in 2025.
• According to Business Quant data, EPS (Basic) over the past three periods registered -$0.13, -$0.36, and -$1.46 for Q4 2025, Q3 2025, and Q2 2025 respectively.